What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study.
Fabrice BonnetHungta ChenAndrew CooperMarília Brito GomesLi-Nong JiPaul LeighLarisa RamirezMarina V ShestakovaIichiro ShimomuraAfrah SiddiquiFengming TangJiten VoraHirotaka WatadaKamlesh Khunti F MedSciPublished in: Diabetes, obesity & metabolism (2021)
In patients with poor glycaemic control at initiation of second-line therapy, early attainment of HbA1c <7.0% appears predictive of long-term glycaemic control, suggesting that timely modification of treatment strategies in patients with elevated HbA1c after 6 months is important to minimize therapeutic inertia.